US5240614A
(en)
*
|
1992-01-10 |
1993-08-31 |
Baxter International Inc. |
Process for removing unwanted materials from fluids and for producing biological products
|
US8303944B2
(en)
*
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
ES2551352T3
(es)
*
|
2007-07-05 |
2015-11-18 |
Array Biopharma, Inc. |
Pirimido ciclopentanos útiles para el tratamiento de enfermedades inflamatorias o hiperproliferativas
|
CN102015692A
(zh)
*
|
2008-02-12 |
2011-04-13 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP2012513410A
(ja)
|
2008-12-23 |
2012-06-14 |
アボット・ラボラトリーズ |
抗ウイルス化合物
|
US8541424B2
(en)
|
2008-12-23 |
2013-09-24 |
Abbott Laboratories |
Anti-viral compounds
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
US8394968B2
(en)
|
2009-02-17 |
2013-03-12 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8420686B2
(en)
*
|
2009-02-17 |
2013-04-16 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole antivirals
|
US8242156B2
(en)
*
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
US8188132B2
(en)
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
WO2010094977A1
(en)
*
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
MY160130A
(en)
|
2009-02-27 |
2017-02-28 |
Enanta Pharm Inc |
Hepatitis c virus inhibitors
|
US9765087B2
(en)
|
2009-02-27 |
2017-09-19 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US8101643B2
(en)
*
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
US8507522B2
(en)
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
EP2410843A4
(en)
*
|
2009-03-27 |
2012-08-08 |
Presidio Pharmaceuticals Inc |
FUSIONED CORE INHIBITORS OF HEPATITIS C
|
US8796466B2
(en)
*
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
RU2541571C2
(ru)
*
|
2009-04-15 |
2015-02-20 |
Эббви Инк. |
Противовирусные соединения
|
CA2760205A1
(en)
*
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
AP3622A
(en)
*
|
2009-05-13 |
2016-03-02 |
Gilead Sciences Inc |
Antiviral compounds
|
EP2435424B1
(en)
|
2009-05-29 |
2015-01-21 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
CA2762885A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
|
US8211928B2
(en)
*
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
SG171708A1
(en)
*
|
2009-06-11 |
2011-07-28 |
Abbott Lab |
Anti-viral compounds to treat hcv infection
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
US8716454B2
(en)
|
2009-06-11 |
2014-05-06 |
Abbvie Inc. |
Solid compositions
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
JP2012533569A
(ja)
|
2009-07-16 |
2012-12-27 |
ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド |
フラビウイルス感染症を治療又は予防するためのベンゾイミダゾール類似体
|
EP2473056A4
(en)
|
2009-09-04 |
2013-02-13 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS
|
EP2475256A4
(en)
*
|
2009-09-11 |
2013-06-05 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
US8822700B2
(en)
*
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8927709B2
(en)
*
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8759332B2
(en)
*
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
EP2475254A4
(en)
*
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
US8703938B2
(en)
*
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
UA108211C2
(xx)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
US20110137633A1
(en)
*
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Anti-viral compounds and methods of identifying the same
|
EP2512480A4
(en)
|
2009-12-14 |
2013-05-15 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CN102791687B
(zh)
*
|
2009-12-18 |
2015-02-11 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
RU2554087C2
(ru)
*
|
2009-12-18 |
2015-06-27 |
Айденикс Фармасьютикалз, Инк. |
5,5-конденсированные ариленовые или гетероариленовые ингибиторы вируса гепатита с
|
CA2785488A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2787309A1
(en)
|
2010-01-25 |
2011-07-28 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8623814B2
(en)
*
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
US8178531B2
(en)
*
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
KR20120124495A
(ko)
*
|
2010-03-04 |
2012-11-13 |
이난타 파마슈티칼스, 인코포레이티드 |
Hcv 복제의 억제제로서의 조합 제약 작용제
|
BR112012022125A2
(pt)
*
|
2010-03-09 |
2016-11-01 |
Merck Sharp & Dhme Corp |
composto, sal de dicloridrato, composição farmacêutica, uso do composto, e, método para tratar um paciente
|
MX2012010918A
(es)
|
2010-03-24 |
2013-01-18 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones por flavivirus.
|
WO2011127350A1
(en)
|
2010-04-09 |
2011-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2011153396A1
(en)
|
2010-06-04 |
2011-12-08 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
JP2013531011A
(ja)
|
2010-06-28 |
2013-08-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染の処置または予防のための化合物および方法
|
WO2012006055A2
(en)
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
AU2011286276A1
(en)
|
2010-07-26 |
2013-01-24 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
WO2012021704A1
(en)
|
2010-08-12 |
2012-02-16 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
JP2013534249A
(ja)
|
2010-08-17 |
2013-09-02 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス科ウイルス感染の処置または予防のための化合物および方法
|
US8859595B2
(en)
|
2010-08-26 |
2014-10-14 |
Rfs Pharma, Llc |
Potent and selective inhibitors of hepatitis C virus
|
CN103459399A
(zh)
*
|
2010-09-29 |
2013-12-18 |
默沙东公司 |
用于治疗丙型肝炎病毒感染的四环吲哚衍生物
|
CA2811662A1
(en)
*
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives for treating hepatitis c virus infection
|
WO2012050848A1
(en)
|
2010-09-29 |
2012-04-19 |
Schering Corporation |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
MX2013004655A
(es)
|
2010-10-26 |
2013-08-27 |
Presidio Pharmaceuticals Inc |
Inhibidores del virus de la hepatitis c.
|
KR20190140486A
(ko)
|
2010-11-17 |
2019-12-19 |
길리애드 파마셋 엘엘씨 |
항바이러스 화합물
|
US20150031884A1
(en)
*
|
2010-12-15 |
2015-01-29 |
Abbvie Inc. |
Anti-viral compounds
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
US8552047B2
(en)
|
2011-02-07 |
2013-10-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2012122716A1
(en)
*
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
JP5669984B2
(ja)
|
2011-05-18 |
2015-02-18 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
5−アザスピロ[2.4]ヘプタン−6−カルボン酸およびその誘導体の製造方法
|
US9303061B2
(en)
|
2011-07-09 |
2016-04-05 |
Sunshine Luke Pharma Co., Ltd. |
Spiro compounds as Hepatitis C virus inhibitors
|
TW201313697A
(zh)
|
2011-07-26 |
2013-04-01 |
Vertex Pharma |
製備噻吩化合物之方法
|
WO2013016499A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparation of thiophene compounds
|
WO2013021344A1
(en)
*
|
2011-08-08 |
2013-02-14 |
Lupin Limited |
Imidazole derivatives as antiviral agents
|
KR20140065427A
(ko)
*
|
2011-08-24 |
2014-05-29 |
글락소스미스클라인 엘엘씨 |
C형 간염에 대한 조합 치료
|
WO2013030750A1
(en)
|
2011-09-01 |
2013-03-07 |
Lupin Limited |
Antiviral compounds
|
WO2013039876A1
(en)
|
2011-09-14 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
JP6073897B2
(ja)
|
2011-09-16 |
2017-02-01 |
ギリアド ファーマセット エルエルシー |
Hcvを処置するための方法
|
BR112013012091A2
(pt)
*
|
2011-11-16 |
2019-09-10 |
Gilead Sciences Inc |
compostos antivirais, seu uso e composição farmacêutica
|
WO2013098313A1
(en)
|
2011-12-28 |
2013-07-04 |
Janssen R&D Ireland |
Hetero-bicyclic derivatives as hcv inhibitors
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
SG11201404475TA
(en)
|
2012-02-10 |
2014-08-28 |
Lupin Ltd |
Antiviral compounds with a dibenzooxaheterocycle moiety
|
EP2827876A4
(en)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
WO2014082380A1
(en)
|
2012-11-29 |
2014-06-05 |
Sunshine Lake Pharma Co., Ltd. |
Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
|
CN103848821B
(zh)
|
2012-11-29 |
2016-10-12 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的螺环化合物、药物组合物及它们的用途
|
WO2014110687A1
(en)
|
2013-01-16 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
|
WO2014110688A1
(en)
*
|
2013-01-16 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Thiophene- sub stitued tetracyclic compounds and methods of use thereof for the treatment of viral diseases
|
ES2771458T3
(es)
|
2013-01-31 |
2020-07-06 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
WO2014134251A1
(en)
|
2013-02-28 |
2014-09-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
US9717712B2
(en)
|
2013-07-02 |
2017-08-01 |
Bristol-Myers Squibb Company |
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
|
US20150023913A1
(en)
|
2013-07-02 |
2015-01-22 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US9775831B2
(en)
|
2013-07-17 |
2017-10-03 |
Bristol-Myers Squibb Company |
Combinations comprising biphenyl derivatives for use in the treatment of HCV
|
PL3650014T3
(pl)
|
2013-08-27 |
2022-01-31 |
Gilead Pharmasset Llc |
Preparat złożony dwóch związków przeciwwirusowych
|
EP3046924A1
(en)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2015065817A1
(en)
|
2013-10-30 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
WO2015089810A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
CN104725365B
(zh)
*
|
2013-12-23 |
2019-02-26 |
南京圣和药业股份有限公司 |
丙型肝炎病毒抑制剂及其应用
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
US9738629B2
(en)
|
2014-01-23 |
2017-08-22 |
Sunshine Lake Pharma Co., Ltd. |
Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
|
WO2015184644A1
(zh)
*
|
2014-06-06 |
2015-12-10 |
爱博新药研发(上海)有限公司 |
抑制丙肝病毒的化合物、药物组合物及其应用
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
CN105985355B
(zh)
*
|
2015-03-01 |
2020-05-05 |
南京圣和药业股份有限公司 |
稠合三环类肝炎病毒抑制剂及其应用
|
WO2017023631A1
(en)
|
2015-08-06 |
2017-02-09 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
GB2552919A
(en)
*
|
2015-11-18 |
2018-02-21 |
Azad Pharmaceutical Ingredients Ag |
Stable amorphous form of daclatasvir
|
WO2018032467A1
(en)
*
|
2016-08-18 |
2018-02-22 |
Merck Sharp & Dohme Corp. |
Chromane-substitued tetracyclic compounds and uses thereof for treatment of viral diseases
|
KR101887969B1
(ko)
*
|
2016-08-30 |
2018-08-13 |
한국과학기술연구원 |
항바이러스 활성을 가지는 카르바졸 화합물
|
CN106543151B
(zh)
*
|
2016-10-18 |
2018-10-30 |
山东师范大学 |
一种基于Co(Ⅱ)的金属有机框架及其制备方法与应用
|
CR20200347A
(es)
|
2018-02-13 |
2020-09-23 |
Gilead Sciences Inc |
Inhibidores pd-1/pd-l1
|
CN112041311B
(zh)
|
2018-04-19 |
2023-10-03 |
吉利德科学公司 |
Pd-1/pd-l1抑制剂
|
KR20230159715A
(ko)
|
2018-07-13 |
2023-11-21 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
AU2019366355B2
(en)
|
2018-10-24 |
2022-10-13 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
EP3891508A1
(en)
|
2018-12-04 |
2021-10-13 |
Bristol-Myers Squibb Company |
Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring
|